← All stocks

Stock news timeline · RPGLIFE

RPG LIFE SCIENCES LTD

News timeline · Last 30 days

23 Aug 2026 – 21 Sep 2026 · Times in IST

Timeline updates
10
Bullish
1
Neutral
8
Bearish
1
Active days
7

News timeline

Showing 10 of 10 updates · Newest first

Thursday, 17 Sep 20261 update

AI sentiment: Neutral 93% confidence

RPG Life Sciences: Plans Meeting With Analysts And Investors On September 22 At 10 AM

Tuesday, 15 Sep 20261 update

AI sentiment: Neutral 75% confidence

RPG Life Sciences Buys API Biz of Raghava; Ops to Continue

RPG Life Sciences' subsidiary acquires API business from Raghava Life Sciences via slump sale. Transfer effective Sept 16, 2026; business continues operations as going concern. Source: ScoutQuest

Friday, 04 Sep 20261 update

AI sentiment: Neutral 53% confidence

RPG Life Sciences: Co Eyes More Acquisitions To Expand API Portfolio Over Next 12 Months - Newspaper

Thursday, 03 Sep 20262 updates

AI sentiment: Neutral 77% confidence

RPG Life Sciences Sets Sep 3 Call on API Update

RPG Life Sciences schedules analyst/investor call on Sep 3, 2026, at 4 PM IST. Call focuses on API business update; MD & CFO to present, registration links shared. Source: ScoutQuest

AI sentiment: Bullish 52% confidence

RPG Life: RPG Active Pharma Acquires Raghava Life Sciences' API Business To Boost Integrated API Strategy.

Wednesday, 02 Sep 20262 updates

AI sentiment: Neutral 83% confidence

RPG Life Shifts API Biz, RPGAP Acquires Actis, Raghava

RPG Life Sciences transferred its API business to RPG Active Pharma for strategic focus. RPGAP partners with InvAscent (40% stake), acquires Actis Generics, Raghava Life Sciences to expand. Source: ScoutQuest

AI sentiment: Neutral 85% confidence

RPG Life Sciences to Buy API Biz for ₹135 Cr, Aims ₹19 Cr FY26 Revenue

RPG Life Sciences' subsidiary to acquire API business generating Rs. 19 Cr FY26 revenue. Acquisition via slump sale worth up to Rs. 135 Cr in cash, pending approvals. Source: ScoutQuest

Tuesday, 01 Sep 20262 updates

AI sentiment: Bearish 53% confidence

RPG Life Sciences Cancels Sep 2 Investor Meet

RPG Life Sciences cancels its investor meet scheduled for Sep 2, 2026. Cancellation informed as per SEBI Regulation 30; record update requested. Source: BSE

AI sentiment: Neutral 89% confidence

Kamdhenu Buys MMR Land for ₹150 Cr, Plans Commercial Project

Kamdhenu Realities acquires 4-acre land in MMR for Rs 150 cr from RPG Life Sciences. Land on Thane Belapur Road has 1.8 mn sq ft developable potential for a commercial project. Source: News18

Tuesday, 25 Aug 20261 update

AI sentiment: Neutral 93% confidence

RPG Life Sciences: To Hold Analyst And Investor Meeting On September 2